Ligand validation:2A75

FSI: 5-acetamido-3,5-dideoxy-3-fluoro-D-erythro-alpha-L-manno-non-2-ulopyranosonic acid

FSI is a Ligand Of Interest in 2A75 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2A75_FSI_A_700	74%	27%	0.123	0.952	1.77	1.17	5	2	0	0	100%	0.9545
2FHR_FSI_A_700	94%	13%	0.064	0.963	2.03	1.96	2	7	0	0	100%	0.9545
2VK7_FSI_A_2693	100%	35%	0.037	0.981	1.33	1.24	4	2	2	0	100%	0.9545
2AH2_FSI_A_700	98%	25%	0.067	0.987	1.67	1.4	2	2	0	0	100%	0.9545
4WEG_FSI_A_515	93%	33%	0.083	0.976	0.67	1.93	-	4	0	0	100%	0.2864
5F9T_FSI_B_802	87%	61%	0.092	0.965	0.63	0.84	-	-	0	0	100%	0.9545
4H52_FSI_B_508	83%	15%	0.087	0.946	2.35	1.46	7	7	0	0	100%	0.9545

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.